Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03151330 · ClinicalTrials.gov registry record · NA
Serum Assessment of Preterm Birth Outcomes Compared to Historical Controls: AVERT PRETERM TRIAL
A NA study, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- NA
- Development phase
- 1,873
- Enrollment target
NCT03151330 is a NA study that has completed, run by Christiana Care Health Services. The registered enrollment target is 1,873 participants.
The verdict
NCT03151330, a NA study, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,873 participants
- Enrollment target
Study Summary
Background: Preterm birth (PTB) remains the leading cause of neonatal mortality and long term disability throughout the world. Recently treatments early in pregnancy such as progesterone, cervical support and maternal support have been demonstrated to delay delivery amongst at risk women. Nonetheless, the majority of women who are at risk are not identified using current screening modalities. Hypothesis: A cohort of pregnancies who are screened using the PreTRM® test around 20 weeks gestation in which a bundle of interventions is given for elevated PreTRM® risk will show either decreased neonatal morbidity/and mortality (measured as a composite score, "NMI"), or decreased length of neonatal stay in the hospital (NNOLOS). Secondarily, they will show an increase in gestational age at birth (GAB) and a reduction in length of neonatal NICU stay (NICULOS), compared to an unscreened historical control group. Study Design Type: Prospective cohort study of screened women compared to a historical control of 10000 women.
Interventions
- OTHER Screened Arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,873 participants |
| Start Date | 2018-06-15 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03151330
The ClinicalTrials.gov registry entry for NCT03151330 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,873 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christiana Care Health Services, which has 82 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Screened Arm is the first listed.
NCT03151330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03151330 about?
NCT03151330 is a clinical study titled "Serum Assessment of Preterm Birth Outcomes Compared to Historical Controls: AVERT PRETERM TRIAL". Background: Preterm birth (PTB) remains the leading cause of neonatal mortality and long term disability throughout the world. Recently treatments early in pregnancy such as progesterone, cervical support and maternal support have been demonstrated to delay delivery amongst at risk women. Nonetheles...
What is the current status of trial NCT03151330?
This trial is currently completed. It is a NA study. The enrollment target is 1,873 participants. The study started on 2018-06-15. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT03151330?
The interventions under investigation include: Screened Arm (OTHER).
Who is sponsoring clinical trial NCT03151330?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.